Approval · Notice of Compliance 4521 · 1996
HYZAAR: Notice of Compliance 4521
Issued November 15, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4521
- Date
- November 15, 1996
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Angiotensin II receptor antagonist and diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYZAAR | 02230047 | Marketed |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- LOSARTAN POTASSIUM 50 MG per TAB